Concordia International

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CXRXF and buy or sell other stocks, ETFs, and their options commission-free!

About CXRXF

ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. 

CEO
Steffen Wagner
CEOSteffen Wagner
Employees
Employees
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2010
Founded2010
Employees
Employees

CXRXF Key Statistics

Market cap
834.46M
Market cap834.46M
Price-Earnings ratio
-8.19
Price-Earnings ratio-8.19
Dividend yield
Dividend yield
Average volume
1.54K
Average volume1.54K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$18.00
52 Week high$18.00
52 Week low
$2.13
52 Week low$2.13

Stock Snapshot

The current Concordia International(CXRXF) stock price is $10.89, with a market capitalization of 834.46M. The stock trades at a price-to-earnings (P/E) ratio of -8.19.

On 2026-03-14, Concordia International(CXRXF) stock opened at —, reached a high of —, and a low of —.

The Concordia International(CXRXF)'s current trading volume is 0, compared to an average daily volume of 1.54K.

During the past year, Concordia International(CXRXF) stock moved between $2.13 at its lowest and $18.00 at its peak.

During the past year, Concordia International(CXRXF) stock moved between $2.13 at its lowest and $18.00 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.